x

Information for patients with UnitedHealthcare or Oxford commercial insurance: Read more before booking an appointment.

Charles A Powell
Video Visit Available
Accepting New Patients
Mount Sinai Verified Doctors IconMount Sinai Doctors

Charles A Powell, MD, MBA

Pulmonary Medicine (Lung), Internal Medicine, Critical Care

White Phone Icon212-241-5656
Calender Icon
Book an Appointment
White Right Arrow

About Me

Charles A. Powell, MD, MBA is Professor of Medicine, and System Division Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai. He received his medical degree from University of Chicago and trained in Internal Medicine at Columbia University and in Pulmonary and Critical Care Medicine at Boston University. The primary focus of Dr. Powell’s clinical and research activities are lung nodules and cancer. Dr. Powell is NIH funded, has published over 150 articles, and directs an NIH funded translational sciences laboratory that examines the genomics of lung cancer. A particular area of focus is on deconvoluting the biology and genomics of early-stage lung adenocarcinoma for which recent advances have modified the diagnosis and approach to these tumors. He also directs research programs focused on applications of machine learning and artificial intelligence to advance diagnosis and treatment of respiratory diseases.

Dr. Powell is the CEO of the Mount Sinai Respiratory Institute that brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, lung cancer, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD) and bronchiectasis.

He was the founding chair of the American Thoracic Society Assembly on Thoracic Oncology and he sees patients in consultation regarding lung nodules and lung cancer. Dr Powell’s international reputation in the field is demonstrated by his election as President of the Fleischner Society and by his leadership roles in the International Society of Respiratory Disease. He is chair of the International Multidisciplinary Adjudication Committee to evaluate interstitial lung disease adverse events in cancer clinical trials of antibody-drug conjugates that are sponsored by Daiichi Sankyo Inc. and Astra Zeneca Ltd.

Language
English
Position
DIRECTOR, MOUNT SINAI-NATIONAL JEWISH HEALTH RESPIRATORY INSTITUTE, PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
Hospital Affiliations
  • Mount Sinai Beth Israel
  • Mount Sinai Morningside
  • Mount Sinai Brooklyn
  • Mount Sinai Queens
  • The Mount Sinai Hospital
  • Mount Sinai West
Multi-Disciplinary Training Areas

Artificial Intelligence and Emerging Technologies in Medicine [AIET]